Practice variation in long-term secondary stroke prevention in the Netherlands
|
|
- Emmeline Lawson
- 5 years ago
- Views:
Transcription
1 C H A P T E R 8 Practice variation in long-term secondary stroke prevention in the Netherlands Sander M. van Schaik Blanche S. de Vries Henry C. Weinstein Marieke C. Visser Renske M. van den Berg-Vos Journal of Stroke and Cerebrovascular Diseases 2015;24: _final opmaakbestand.indd :21
2 A B S T R A C T Background Stroke guidelines emphasize the importance of adequate vascular risk factor assessment and management in transient ischemic attack (TIA) and ischemic stroke patients, but it is not clear how these guidelines are applied in routine clinical practice. The limited data that are available indicate that TIA and ischemic stroke patients often do not receive the recommended interventions. The aim of this study was to investigate practice variations in long-term secondary stroke prevention in the Netherlands. Methods Between June and December 2013, an invitation for a web-based survey was sent to 90 Dutch neurologists with a special interest in stroke neurology. This web-based survey contained questions regarding the organization of outpatient care for TIA and ischemic stroke patients after initial hospital assessment, pharmacologic treatment, and nonpharmacologic strategies for long-term secondary prevention. Results In total, 84 (93%) neurologists completed the survey. Although nearly all respondents reported that they follow-up TIA and ischemic stroke patients after initial hospital assessment, the number of follow-up visits and the follow-up duration were variable. A similar variation was found in treatment targets levels for both blood pressure and low-density lipoprotein cholesterol. Regarding nonpharmacologic strategies for long-term secondary stroke prevention, most respondents inform their TIA and ischemic stroke patients about the importance of smoking cessation. There is considerably less attention for the other lifestyle risk factors. Conclusions We found considerable practice variation in long-term secondary stroke prevention. These variations may have an impact on the risk for stroke recurrence and cardiovascular disease in general. 126 _final opmaakbestand.indd :21
3 Introduction Stroke is a major cause of death and disability world-wide. Evidence from randomized trials and meta-analyses for the effectiveness of long-term secondary prevention strategies after transient ischemic attack (TIA) and ischemic stroke is compelling. A combination of antithrombotic therapy, blood pressure control, statins, dietary modification, and exercise lowers the risk of recurrent stroke and other future cardiovascular events. 1-5 The combination of these strategies could result in a cumulative relative risk reduction of 80%. 6 Therefore, national and international guidelines emphasize the importance of adequate risk factor assessment and management in TIA and ischemic stroke patients, but it is not clear how these guidelines are applied in routine clinical practice Few studies have focused on the quality of care regarding long-term secondary stroke prevention. The limited data that are available indicate that despite advances in treatment, TIA and ischemic stroke patients often do not receive the recommended interventions We hypothesized that considerable variations in long-term secondary stroke prevention may exist among neurologists in the Netherlands. We used an online survey to seek the opinion of Dutch neurologists about long-term secondary stroke prevention. The results of this survey can be used to improve future quality of care for these patients. M e t h o d s We analyzed national and international TIA and ischemic stroke guidelines to identify topics and situations where practice variation, regarding long-term secondary prevention for TIA and ischemic stroke patients, could be expected. An online survey creator ( 127 _final opmaakbestand.indd :21
4 C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S was used to develop a web-based survey, which included multiple choice questions, multi-answer multiple choice questions, and free-text fields for additional comments. This survey was divided into 3 parts. The first part contained questions on how outpatient care for TIA and ischemic stroke patients is organized after initial hospital assessment (Table 1). The second part of the survey consisted of questions about pharmacologic treatment regarding long-term secondary stroke prevention (Table 2). The third part contained questions regarding nonpharmacologic strategies for long-term secondary stroke prevention (Table 3). Between June and December 2013, an invitation for an anonymous web-based survey was sent to 90 Dutch neurologists with a special interest in stroke neurology, working in 90 different hospitals. Most of them participated in an earlier online survey on variation in clinical practice of intravenous thrombolysis in stroke in the Netherlands. 15 To increase the response rate, a monthly reinvitation was sent. Results Ninety neurologists were invited to participate, of whom 84 (93%) completed the survey. Most of the respondents (92%) worked in nonacademic hospitals. The Organization of Outpatient Care for TIA and Ischemic Stroke Patients Almost all respondents (98%) reported that they follow-up TIA and ischemic stroke patients after initial hospital assessment. The average number of follow-up visits were variable, ranging from 1 visit in 34 (40%) respondents to 4 visits or more in 2 (2.4%) respondents. The follow-up duration ranged from 0-3 months (62%) to 12 months or more (4.8%). Respondents reported that during follow-up patients are managed by neurologists (76%), neurology residents (15%), physician 128 _final opmaakbestand.indd :21
5 TABLE 1 Questions regarding the organisation of long-term secondary prevention after TIA and ischemic stroke Questions n (%) Do you follow-up TIA and ischemic stroke patients after initial hospital assessment? Yes 82 (98) No 2 (2.4) What is the average number of follow-up visits? 1 visit 34 (40) 2 visits 37 (44) 3 visits 9 (11) 4 visits ore more 2 (2.4) Did not specify 2 (2.4) What is the average follow-up duration? 0-3 months 52 (62) 4-6 months 18 (21) 7-12 months 8 (9.5) >12 months 4 (4.8) Did not specify 2 (2.4) Who does manage your patients after TIA and ischemic stroke with regard to long-term secondary prevention? (more than one answer allowed) Neurologist 64 (76) Neurology resident* 13 (15) Physician assistant 26 (31) Stroke nurse 27 (32) Other 9 (11) Did not specify 2 (2.4) Who is primarily responsible for your patients after TIA and ischemic stroke with regard to long-term secondary prevention? Neurologist 22 (26) General practitioner 36 (43) Physician assistant 6 (7.1) The stroke nurse 3 (3.6) The internist 1 (1.2) Other 12 (14) No one is primarily responsible 4 (4.8) Who, in your opinion, should ideally be responsible for patients after TIA and ischemic stroke with regard to long-term secondary prevention? Neurologist 21 (25) General practitioner 42 (50) Physician assistant 6 (7.1) The stroke nurse 7 (8.3) The internist 2 (2.4) Other 6 (7.1) * neurology residency training programs are not limited to academic centers in the Netherlands. 129 _final opmaakbestand.indd :21
6 TABLE 2 Questions regarding pharmacological treatment for patients after TIA or ischemic stroke n (%) C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S Do you use clopidogrel monotherapy as first-line antiplatelet agent in long-term secondary stroke prevention, instead of the combination aspirin/dipyridamol? Always 10 (12) Usually 11 (13) Sometimes 57 (68) Never 6 (7.1) Have you prescribed a NOAC in the past year? Yes 21 (25) No 63 (75) Do you initiate antihypertensive therapy for long-term secondary stroke prevention? Always 9 (11) Usually 28 (33) Sometimes 37 (44) Never 10 (12) Which blood pressure target level do you aim for? The lower, the better 12 (14) 140/90 mm Hg for all 22 (26) 140/90 mm Hg, 130/80 mmhg for patients with diabetes 15 (18) 130/80 mm Hg for all 19 (23) Other 8 (9.5) Did not specify 10 (12) Do you prescribe antihypertensive therapy in normotensive patients? Always 1 (1.2) Usually 10 (12) Sometimes 29 (35) Never 34 (40) Did not specify 10 (12) Do you initiate lipid-lowering therapy for long-term secondary stroke prevention? Always 53 (63) Usually 25 (30) Sometimes 5 (6.0) Never 1 (1.2) Do you routinely assess LDL cholesterol levels after initiating statin therapy? Yes 34 (40) No 49 (58) Did not specify 1 (1.2) Which LDL-cholesterol target level do you aim for? No target 17 (20) <100 mg/dl 51 (61) <70 mg/dl 8 (9.5) Depending on stroke subtype 2 (2.4) Other 5 (6.0) Did not specify 1 (1.2) 130 NOAC = New oral anticoagulant _final opmaakbestand.indd :21
7 TABLE 3 Questions regarding non-pharmacological strategies for patients after TIA or ischemic stroke: Do you systematically discuss the following lifestyle risk factors with patients after TIA or ischemic stroke? Always Usually Sometimes Never Tobacco use 74 (88%) 10 (11%) 0 0 Heavy alcohol use 45 (53%) 22 (26%) 16 (19%) 1 (1.2%) Physical inactivity 35 (41%) 34 (40%) 14 (16%) 1 (1.2%) Unhealthy diet 30 (35%) 29 (34%) 20 (23%) 5 (6.0%) Non-adherence to medication 35 (41%) 25 (29%) 21 (25%) 3 (3.6%) assistants (31%), and stroke nurses (32%). Table 1 details responses to questions regarding the organization of outpatient care for TIA and ischemic stroke patients. Twenty-two (26%) respondents stated that the neurologist is primarily responsible for long-term secondary prevention for TIA and ischemic stroke patients after initial hospital assessment, 36 (43%) reported that the general practitioner is primarily responsible, 6 (7.1%) the physician assistant, 3 (3.6%) the stroke nurse, 1 (1.2%) the internist, and 4 (4.8%) reported that no one is primarily responsible. Regarding who ideally should be responsible for long-term secondary prevention after TIA and ischemic stroke, 42 (50%) respondents answered the general practitioner, 21 (25%) the neurologist, 7 (8.3%) the stroke nurse, 6 (7.1%) the physician assistant, 2 (2.4%) the internist, and 6 (7.1%) preferred a combination of either the neurologist and the general practitioner or the latter and the stroke nurse. Phar macological Treatment for Long-ter m Secondary Stroke Prevention Overall, 75 (89%) respondents reported that the pharmacologic treatment for TIA and ischemic stroke patients is described in a local protocol. Ten (12%) respondents use clopidogrel monotherapy as first-line antiplatelet agent in secondary stroke prevention, instead of the in the Netherlands recommended combination of acetylsalicylic acid and dipyridamole (Table 2). Among those respondents who did usually (13%) or sometimes (68%) use clopidogrel in secondary 131 _final opmaakbestand.indd :21
8 C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S stroke prevention, the most common reason cited were side effects of acetylsalicylic acid or dipyridamole (66%). Other reported reasons included recurrent TIA or ischemic stroke while on acetylsalicylic acid and dipyridamole (20%), acetylsalicylic acid resistance (13%), similarity in efficacy to aspirin and dipyridamole (9.5%), ease of administration (9.5%), and low costs (7.1%). When asked whether they used new oral anticoagulants as long-term secondary stroke prevention for patients with atrial fibrillation during the last year, 21 (25%) respondents reported that they did. Most respondents (83%) stated that they are planning to prescribe new oral anticoagulants in the near future. Eleven percent of respondents reported that they always initiate antihypertensive therapy for secondary stroke prevention in patients with high blood pressure. On the contrary, 10 (12%) respondents never initiate anti-hypertensive therapy for secondary stroke prevention. Most respondents usually (33%) or sometimes (44%) initiate antihypertensive therapy for secondary stroke prevention in patients with high blood pressure. The most frequently prescribed antihypertensive agents were angiotensin-converting enzyme inhibitors (71%) and diuretics (63%). Less commonly used antihypertensive agents were calcium channel blockers (26%), angiotensin receptor blockers (17%), and beta blockers (13%). More than one third (38%) of the respondents use 2 antihypertensive agents in fixed dose combinations if indicated. The blood pressure targets reported were variable, 22 (26%) respondents use a target of 140/90 mm Hg or less for all patients, 19 (23%) respondents use a target of 130/80 m mhg or less for all patients, and 15 (18%) respondents use a target of 140/90 mm Hg or less or 130/80 mm Hg or less for patients with diabetes mellitus. Only the minority of the respondents always (1.2%) or usually (12%) prescribe antihypertensive agents in normotensive stroke patients. Fiftyfive (66%) of the respondents take patient age into account when prescribing antihypertensive agents. In total, 53 (63%) of respondents stated that they always start a statin for secondary stroke prevention. A total of 34 (40%) respondents 132 _final opmaakbestand.indd :21
9 reported that they check their patients low-density lipoprotein cholesterol (LDL-C) levels routinely. Most (70%) respondents use a treat to target strategy, 51 (61%) use an LDL-C target level of less than 100 mg/dl (< 2.5 mmol/l), and 8 (9.5%) use a level of less than 70 mg/dl (< 1.8 mmol/l). Seventeen (20%) respondents do not use a specific LDL-C target, and 2 (2.4%) respondents use an LDL-C target depending on the ischemic stroke subtype. More than half of the respondents take patient age into account when deciding whether statin prescription is indicated. Nonphar macologic Strategies for Long-ter m Secondary Stroke Prevention Overall, 42 (50%) of the respondents stated that the nonpharmacologic treatment for long-term secondary stroke prevention, regarding lifestyle risk factors, is described in a local protocol. The assessment and documentation of the lifestyle risk factors are variable. Nearly all respondents systematically ask for and document tobacco use (99%) and alcohol use (98%), if applicable. Less systematically body weight (68%), body mass index (42%), physical inactivity (42%), unhealthy diet (23%), and waist circumference (6.0%) are asked for and documented. Forty-four (52%) respondents always deliver lifestyle modification advice to TIA and ischemic stroke patients. Overall, 74 (88%) respondents always and 10 (12%) respondents usually discuss the importance of smoking cessation in secondary stroke prevention. The other lifestyle risk factors are less systematically addressed (Table 3). Discussion As hypothesized, we found considerable practice variation in longterm secondary stroke prevention among Dutch neurologists. We found considerable variation in the organization of outpatient care after initial hospital assessment, pharmacologic treatments, and 133 _final opmaakbestand.indd :21
10 C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S nonpharmacologic strategies. To our knowledge, this is the first study investigating practice variations in long-term secondary stroke prevention. Although nearly all respondents reported that they follow-up TIA and ischemic stroke patients after initial hospital assessment, the type of health care workers who delivered the care, the number of follow-up visits, and follow-up duration were highly variable. There was also considerable disagreement among the respondents on who ideally should be responsible for long-term secondary prevention after TIA and ischemic stroke. Half of the respondents stated that the general practitioner should primarily be responsible for long-term secondary stroke prevention, whereas the other half of the respondents favored a hospital-based strategy. To date, it is unclear who is best suited to coordinate cardiovascular risk management for TIA and ischemic stroke patients, and further studies are needed on this topic. Irrespectively of who is or should be responsible for long-term secondary prevention after TIA and ischemic stroke, all involved health-care professionals should in our opinion work in a coordinated manner and attempt to reach a targeted standard of care. Therefore, a close collaboration between primary and secondary care is of paramount importance. Since the results of the Profess trial, which showed similar rates of stroke recurrence with the combination of acetylsalicylic acid and dipyridamole compared with clopidogrel, the latter is a convenient alternative for antithrombotic therapy. 16 This is in accordance with daily practice as in our survey 12% of respondents always and 13% usually prescribe clopidogrel monotherapy. Most of the (remaining) respondents answered that they sometimes prescribe clopidogrel in secondary stroke prevention. It seems that, although the combination of acetylsalicylic acid and dipyridamole still is the first-line antithrombotic therapy for secondary stroke prevention in the Netherlands, the use of clopidogrel monotherapy is increasing. Together with the use of antihypertensive agents in fixed dose combinations, this will improve medication adherence in TIA and ischemic stroke patients _final opmaakbestand.indd :21
11 This survey shows there is considerable variation in blood pressure treatment targets. Most respondents use a blood pressure target of 140/90 mm Hg or less or 130/80 mm Hg or less for all patients. This variation could possibly be explained by the lack of an absolute target blood pressure level in international ischemic stroke guidelines, although the Dutch guideline for cardiovascular risk management advises a blood pressure target of 140/90 mm Hg or less for patients with cardiovascular disease. In addition, it is remarkable that although national and international guidelines recommend starting blood pressure lowering therapy regardless the initial blood pressure, only 1 (1.2%) respondent always and 10 (12%) respondents usually commence blood pressure lowering therapy in normotensive TIA or ischemic stroke patients A similar variation in treatment targets was found regarding lipidlowering therapy for secondary stroke prevention. Although 53 (63%) respondents always and 25 (30%) respondents usually commence lipid-lowering therapy, only 51 (61%) respondents use the national guideline recommended LDL-C target of less than 100 mg/dl A possible explanation for this variation could be the unclear association between LDL-C levels and stroke risk in TIA and ischemic stroke patients. Until now, studies comparing normal versus intensive LDL-C lowering strategies in patients after TIA or ischemic stroke are lacking. This may have resulted in the fact that a substantial part of the neurologists prescribe statins to ischemic stroke patients without aiming for a specific LDL-C level. Half of the respondents reported that treatment regarding lifestyle modification advice is described in a local protocol. Most respondents always inform their TIA and ischemic stroke patients about the importance of smoking cessation. There is considerably less attention for the other lifestyle risk factors. Again, these results are in contrast with the targeted standard of care in national and international guidelines Thus, regarding lifestyle modification, there is still much to be gained. To improve health behavior (ie, physical activity, 135 _final opmaakbestand.indd :21
12 C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S medication adherence, cessation of smoking, moderate alcohol intake, and healthy eating), we find that effective behavior change interventions, for example, motivational interviewing, need to be incorporated in routine clinical practice for TIA and ischemic stroke patients. 18 Comprehensive cardiac rehabilitation programs, including a physical exercise program, reduce mortality in patients after myocardial infarction. 19 Although TIA, ischemic stroke, and myocardial infarction share risk factors and pathologic mechanisms, a specific rehabilitation program to improve cardiorespiratory fitness, to influence secondary prevention targets, and to systematically address cardiovascular lifestyle targets has not been implemented for TIA or ischemic stroke patients. Improving adherence to guidelines and cardiovascular lifestyle changes by standardizing poststroke care, mirroring practice in cardiac rehabilitation programs, could be a promising method for increasing effectiveness of secondary stroke prevention. The strength of this study lies in the high response rate (93%) and the fact that it was a relatively large sample of Dutch neurologists, covering nearly all Dutch Hospitals. Our study has some limitations. First, a problem inherent to an online survey is that management as reported in a questionnaire does not always reflect actual practice. Despite the high response rate of our online survey, participating stroke neurologists were not necessarily representative for the local policy. Second, because this survey does not measure the quality of care, it is not possible to determine which approach to long-term secondary prevention reduces recurrent stroke and other cardiovascular disease most. Third, because all Dutch inhabitants have an assigned general practitioner who treats chronic illnesses, including cardiovascular diseases, quality of stroke care may be better than what is perceived in this survey. Because of these factors, care must be taken into extrapolating the results. In the Netherlands, currently 136 _final opmaakbestand.indd :21
13 a national database, developed by a national knowledge-based network for stroke professionals Kennisnetwerk CVA Nederland has been developed and is being implemented in collaboration with the Dutch Institute for Clinical Auditing, in which baseline variables and functional outcome at 3 months after stroke will be prospectively assessed, enabling evaluation and prognostification of stroke care in the future. In conclusion, our survey shows considerable variation in long-term secondary stroke prevention among Dutch neurologists. These variations may have an impact on the risk for stroke recurrence and cardiovascular disease in general. Further studies are needed to address this issue and to detect possible causes for the gap between guideline recommendations and routine clinical practice, to eventually improve quality of care for TIA and ischemic stroke patients. Acknowledgment The authors would like to thank all respondents of the survey for participation. The authors would like to thank Ms. G.M. McLean for her contribution to the article. 137 _final opmaakbestand.indd :21
14 REFERENCES C H A P T E R 8 : P R A C T I C E V A R I A T I O N I N L O N G - T E R M S E C O N D A R Y S T R O K E P R E V E N T I O N I N T H E N E T H E R L A N D S 1. Z h a n g H, T h i j s L, S t a e s s e n J A. B l o o d p re s s u re l o w e r i n g f o r p r i m a r y a n d s e c o n d a r y p re v e n t i o n o f s t ro k e. H y p e r t e n s i o n ; 4 8 : H a n k e y G J, E i k e l b o o m J W. A n t i t h ro m b o t i c d r u g s f o r p a t i e n t s w i t h i s c h a e m i c s t ro k e a n d t r a n s i e n t i s c h a e m i c a t t a c k t o p re v e n t re c u r re n t m a j o r v a s c u l a r e v e n t s. L a n c e t N e u ro l ; 9 : R o t h w e l l P M, A l g r a A, A m a re n c o P. M e d i c a l t re a t m e n t i n a c u t e a n d l o n g - t e r m s e c o n d a r y p re v e n t i o n a f t e r t r a n s i e n t i s c h a e m i c a t t a c k a n d i s c h a e m i c s t ro k e. L a n c e t ; : M a n k t e l o w B N, P o t t e r J F. I n t e r v e n t i o n s i n t h e m a n a g e m e n t o f s e r u m l i p i d s f o r p re v e n t i n g s t ro k e re c u r re n c e. C o c h r a n e D a t a b a s e S y s t R e v : C D H a n k e y G J. S e c o n d a r y s t ro k e prevention. Lancet Neurol 2014;13: H a c k a m D G, S p e n c e J D. C o m b i n i n g m u l t i p l e a p p ro a c h e s f o r t h e s e c o n d a r y p re v e n t i o n o f v a s c u l a r e v e n t s a f t e r s t ro k e : a q u a n t i t a t i v e m o d e l i n g s t u d y. S t ro k e ; 3 8 : F u r i e K L, K a s n e r S E, A d a m s R J, e t a l. G u i d e l i n e s f o r t h e p re v e n t i o n o f s t ro k e i n p a t i e n t s w i t h s t ro k e o r t r a n s i e n t i s c h e m i c a t t a c k : a g u i d e l i n e f o r h e a l t h c a re p ro f e s s i o n a l s f ro m t h e a m e r i c a n h e a r t a s s o c i a t i o n / a m e r i c a n stroke association. Stroke 2011;42: P e r k J, d e B a c k e r G, G o h l k e H, e t a l. E u ro p e a n G u i d e l i n e s o n c a rd i o v a s c u l a r d i s e a s e p re v e n t i o n i n c l i n i c a l p r a c t i c e ( v e r s i o n ). T h e F i f t h J o i n t Ta s k F o rc e o f t h e E u ro p e a n S o c i e t y o f C a rd i o l o g y a n d O t h e r S o c i e t i e s o n C a rd i o v a s c u l a r D i s e a s e P re v e n t i o n i n C l i n i c a l P r a c t i c e ( c o n s t i t u t e d b y re p re s e n t a t i v e s o f n i n e s o c i e t i e s a n d b y i n v i t e d e x p e r t s ). E u r H e a r t J ; 3 3 : T h e E u ro p e a n S t ro k e O rg a n i s a t i o n ( E S O ) E x e c u t i v e C o m m i t t e e a n d t h e E S O Wr i t i n g C o m m i t t e e. G u i d e l i n e s f o r M a n a g e m e n t o f I s c h a e m i c S t ro k e a n d Tr a n s i e n t I s c h a e m i c A t t a c k Cerebrovasc Dis 2008;25: M u l t i d i s c i p l i n a i re r i c h t l i j n c a rd i o v a s c u l a i r r i s i c o m a n a g e m e n t, h e r z i e n i n g B o h n S t a f l e u v a n Loghum, ISBN S a p o s n i k G, G o o d m a n S G, L e i t e r L A, e t a l. A p p l y i n g t h e E v i d e n c e : D o P a t i e n t s W i t h S t ro k e, C o ro n a r y A r t e r y D i s e a s e, o r B o t h A c h i e v e S i m i l a r Tre a t m e n t G o a l s? S t ro k e ; 4 0 : C h w o j n i c k i K, Ya g e n s k y A, W i e r u c k i L, e t a l. A s s e s s m e n t o f t h e q u a l i t y o f s e c o n d a r y i s c h e m i c s t ro k e p re v e n t i o n i n s e l e c t e d u r b a n a re a s o f P o l a n d a n d U k r a i n e : t h e A S C E P s t u d y re s u l t s. E u r N e u ro l ; 6 5 : H o r n n e s N, L a r s e n K, B o y s e n G. L i t t l e c h a n g e o f m o d i f i a b l e r i s k f a c t o r s 1 y e a r a f t e r s t ro k e : a p i l o t s t u d y. I n t J S t ro k e ; 5 : L i C, E n g s t ro m G, J a n z o n L, e t. a l. L o n g - t e r m s t ro k e p ro g n o s i s i n re l a t i o n t o m e d i c a l p re v e n t i o n a n d l i f e s t y l e f a c t o r s. A p ro s p e c t i v e p o p u l a t i o n - b a s e d s t u d y. C e re b ro v a s c D i s ; 2 5 : B a u e r A, L i m b u rg M, V i s s e r M C. Va r i a t i o n i n C l i n i c a l P r a c t i c e o f I n t r a v e n o u s T h ro m b o l y s i s i n S t ro k e i n t h e N e t h e r l a n d s. C e re b ro v a s c D i s E x t r a ; 3 : S a c c o R L, D i e n e r H - C, Yu s u f S, e t a l. A s p i r i n a n d E x t e n d e d - R e l e a s e D i p y r i d a m o l e v e r s u s C l o p i d o g re l f o r R e c u r re n t S t ro k e. N E n g l J M e d ; : T h o m S, P o u l t e r N, F i e l d J, e t a l. E ff e c t s o f a f i x e d - d o s e c o m b i n a t i o n s t r a t e g y o n a d h e re n c e a n d r i s k f a c t o r s i n p a t i e n t s w i t h o r a t h i g h r i s k o f C V D : t h e U M P I R E r a n d o m i z e d c l i n i c a l t r i a l. J A M A ; : _final opmaakbestand.indd :21
15 18. Ta y l o r R S, B ro w n A, E b r a h i m S, e t a l. E x e rc i s e - b a s e d re h a b i l i t a t i o n f o r p a t i e n t s w i t h c o ro n a r y h e a r t d i s e a s e : s y s t e m a t i c re v i e w a n d m e t a - a n a l y s i s o f r a n d o m i z e d c o n t ro l l e d t r i a l s. A m J M e d ; : _final opmaakbestand.indd :21
Downloaded from:
Antithrombotic Trialists (ATT), Collaboration; Baigent, C; Blackwell, L; Collins, R; Emberson, J; Godwin, J; Peto, R; Buring, J; Hennekens, C; Kearney, P; Meade, T; Patrono, C; Roncaglioni, MC; Zanchetti,
More informationComparing the effects of two treatments on two ordinal outcome variables
Working Papers in Statistics No 2015:16 Department of Statistics School of Economics and Management Lund University Comparing the effects of two treatments on two ordinal outcome variables VIBEKE HORSTMANN,
More informationLessons learned from a decade of battling chronic disease on the front lines of local companies.
Lessons learned from a decade of battling chronic disease on the front lines of local companies. Effecting Positive Change in Employee Health AGENDA Our Experience and Methods Data on employee health What
More informationBINF 702 SPRING Chapter 8 Hypothesis Testing: Two-Sample Inference. BINF702 SPRING 2014 Chapter 8 Hypothesis Testing: Two- Sample Inference 1
BINF 702 SPRING 2014 Chapter 8 Hypothesis Testing: Two-Sample Inference Two- Sample Inference 1 A Poster Child for two-sample hypothesis testing Ex 8.1 Obstetrics In the birthweight data in Example 7.2,
More informationCore Courses for Students Who Enrolled Prior to Fall 2018
Biostatistics and Applied Data Analysis Students must take one of the following two sequences: Sequence 1 Biostatistics and Data Analysis I (PHP 2507) This course, the first in a year long, two-course
More informationProbability and Probability Distributions. Dr. Mohammed Alahmed
Probability and Probability Distributions 1 Probability and Probability Distributions Usually we want to do more with data than just describing them! We might want to test certain specific inferences about
More informationLow-Income African American Women's Perceptions of Primary Care Physician Weight Loss Counseling: A Positive Deviance Study
Thomas Jefferson University Jefferson Digital Commons Master of Public Health Thesis and Capstone Presentations Jefferson College of Population Health 6-25-2015 Low-Income African American Women's Perceptions
More informationThis report details analyses and methodologies used to examine and visualize the spatial and nonspatial
Analysis Summary: Acute Myocardial Infarction and Social Determinants of Health Acute Myocardial Infarction Study Summary March 2014 Project Summary :: Purpose This report details analyses and methodologies
More informationTECHNICAL APPENDIX WITH ADDITIONAL INFORMATION ON METHODS AND APPENDIX EXHIBITS. Ten health risks in this and the previous study were
Goetzel RZ, Pei X, Tabrizi MJ, Henke RM, Kowlessar N, Nelson CF, Metz RD. Ten modifiable health risk factors are linked to more than one-fifth of employer-employee health care spending. Health Aff (Millwood).
More informationApproach to identifying hot spots for NCDs in South Africa
Approach to identifying hot spots for NCDs in South Africa HST Conference 6 May 2016 Noluthando Ndlovu, 1 Candy Day, 1 Benn Sartorius, 2 Karen Hofman, 3 Jens Aagaard-Hansen 3,4 1 Health Systems Trust,
More informationHypothesis Testing, Power, Sample Size and Confidence Intervals (Part 2)
Hypothesis Testing, Power, Sample Size and Confidence Intervals (Part 2) B.H. Robbins Scholars Series June 23, 2010 1 / 29 Outline Z-test χ 2 -test Confidence Interval Sample size and power Relative effect
More informationPhone number: When and how did your pain begin? (a date is required for Medicare and some insurance policies) Date of onset:
C H I R O P R A C T I C O R T H O P E D I C S A N D R E H A B I L I T A T I O N ILJXAi Pain Relief Clinics Please complete all sections. Full Name: Nickname: Gender: M F Age: Race: Date of Birth: I I Family
More informationExtreme Temperature Protocol in Middlesex-London
Clean Air Partnership Webinar March 17, 2009 Extreme Temperature Protocol in Middlesex-London Presented by Iqbal Kalsi, MBA, CPHI(C), CCEP iqbal.kalsi@mlhu.on.ca 1 History Informal monitoring, tracking
More informationDISCRETE PROBABILITY DISTRIBUTIONS
DISCRETE PROBABILITY DISTRIBUTIONS REVIEW OF KEY CONCEPTS SECTION 41 Random Variable A random variable X is a numerically valued quantity that takes on specific values with different probabilities The
More informationProgramme Specification MSc in Cancer Chemistry
Programme Specification MSc in Cancer Chemistry 1. COURSE AIMS AND STRUCTURE Background The MSc in Cancer Chemistry is based in the Department of Chemistry, University of Leicester. The MSc builds on the
More information42. EXTENSIONS AND APPLICATIONS OF COMPARE: WEB PLATFORM TO SELECT THE PRIMARY ENDPOINT IN A RANDOMIZED CLINICAL TRIAL
42. EXTENSIONS AND APPLICATIONS OF COMPARE: WEB PLATFORM TO SELECT THE PRIMARY ENDPOINT IN A RANDOMIZED CLINICAL TRIAL M. Gómez-Mateu and G. Gómez Melis Universitat Politècnica de Catalunya, Department
More informationAuthor's response to reviews
Author's response to reviews Title: Diverse risks of incident cardiovascular disease and all-cause mortality in men and women with low cash margins living alone: cohort data from 60-year-olds Authors:
More informationEndurance, Energy, Healthy Aging
Endurance, Energy, Healthy Aging NR is being extensively researched in major universities and hospitals Effects of NR on metabolism are nothing short of astonishing. Researcher from Weill Cornell Medical
More informationThe World Bank Health System Strengthening and Support Project (P152799)
Public Disclosure Authorized EUROPE AND CENTRAL ASIA Turkey Health, Nutrition & Population Global Practice IBRD/IDA Investment Project Financing FY 2016 Seq No: 3 ARCHIVED on 23-Dec-2016 ISR25849 Implementing
More informationWelcome! Webinar Biostatistics: sample size & power. Thursday, April 26, 12:30 1:30 pm (NDT)
. Welcome! Webinar Biostatistics: sample size & power Thursday, April 26, 12:30 1:30 pm (NDT) Get started now: Please check if your speakers are working and mute your audio. Please use the chat box to
More informationModular Program Report
Modular Program Report Disclaimer The following report(s) provides findings from an FDA initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety
More informationPerson-Time Data. Incidence. Cumulative Incidence: Example. Cumulative Incidence. Person-Time Data. Person-Time Data
Person-Time Data CF Jeff Lin, MD., PhD. Incidence 1. Cumulative incidence (incidence proportion) 2. Incidence density (incidence rate) December 14, 2005 c Jeff Lin, MD., PhD. c Jeff Lin, MD., PhD. Person-Time
More informationHOW TO BUILD A WELLNESS PLAN TO REDUCE STRESS IN YOUR WORKPLACE
HOW TO BUILD A WELLNESS PLAN TO REDUCE STRESS IN YOUR WORKPLACE K e l l y Z i e m k i e w i c z, M B A, R D N, L D N, C D E M a r c h 2 1, 2 0 1 9 NC- I P M A 2 0 1 9 A n n u a l C o n f e r e n c e O
More informationSpatial Variation in Hospitalizations for Cardiometabolic Ambulatory Care Sensitive Conditions Across Canada
Spatial Variation in Hospitalizations for Cardiometabolic Ambulatory Care Sensitive Conditions Across Canada CRDCN Conference November 14, 2017 Martin Cooke Alana Maltby Sarah Singh Piotr Wilk Today s
More informationBIOL 51A - Biostatistics 1 1. Lecture 1: Intro to Biostatistics. Smoking: hazardous? FEV (l) Smoke
BIOL 51A - Biostatistics 1 1 Lecture 1: Intro to Biostatistics Smoking: hazardous? FEV (l) 1 2 3 4 5 No Yes Smoke BIOL 51A - Biostatistics 1 2 Box Plot a.k.a box-and-whisker diagram or candlestick chart
More informationStatistical Testing I. De gustibus non est disputandum
Statistical Testing I De gustibus non est disputandum The Pepsi Challenge "Take the Pepsi Challenge" was the motto of a marketing campaign by the Pepsi-Cola Company in the 1980's. A total of 100 Coca-Cola
More informationKeywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction
PostDoc Journal Vol. 2, No. 3, March 2014 Journal of Postdoctoral Research www.postdocjournal.com QSAR Study of Thiophene-Anthranilamides Based Factor Xa Direct Inhibitors Preetpal S. Sidhu Department
More informationJOINT STRATEGIC NEEDS ASSESSMENT (JSNA) Key findings from the Leicestershire JSNA and Charnwood summary
JOINT STRATEGIC NEEDS ASSESSMENT (JSNA) Key findings from the Leicestershire JSNA and Charnwood summary 1 What is a JSNA? Joint Strategic Needs Assessment (JSNA) identifies the big picture in terms of
More informationTreatment Intake Form
Sally Valentine, PhD, LCSW 1 W. Camino Real, Suite 202, Boca Raton, FL 33432 drsallyvalentine@me.com 561.391.3305 Treatment Intake Form Please complete all information on this form and bring it to your
More informationCOLLEGE OF PHYSICIANS & SURGEONS OF MANITOBA INQUIRY PANEL DECISION
COLLEGE OF PHYSICIANS & SURGEONS OF MANITOBA INQUIRY PANEL DECISION INQUIRY: IC2459 DR. RANDY RAYMOND ALLAN On November 10, 2016, a hearing was convened before an Inquiry Panel (the Panel ) of the College
More informationTitle: Department: Previous Version(s): Replaces:
Title: Department: Pediatric Massive Transfusion Protocol (MTP) Trauma Services Effective Date: 09/2014 Reviewed: Policy and Protocol Previous Version(s): Replaces: **The reader is cautioned to refer to
More informationMathematical Model of Blood Flow in Carotid Bifurcation
Excerpt from the Proceedings of the COMSOL Conference 2009 Milan Mathematical Model of Blood Flow in Carotid Bifurcation E. Muraca *,1, V. Gramigna 1, and G. Fragomeni 1 1 Department of Experimental Medicine
More informationSystematic Review Round 7 Application Form
Systematic Review Round 7 Application Form SR7/1063 1. BASIC PROJECT INFO (i) Title of Proposed Review * Systematic review question.download detailed SR7 questions here Title of the study if more focused
More informationMAT 2379, Introduction to Biostatistics, Sample Calculator Questions 1. MAT 2379, Introduction to Biostatistics
MAT 2379, Introduction to Biostatistics, Sample Calculator Questions 1 MAT 2379, Introduction to Biostatistics Sample Calculator Problems for the Final Exam Note: The exam will also contain some problems
More informationAn Introduction to GLIF
An Introduction to GLIF Mor Peleg, Ph.D. Post-doctoral Fellow, SMI, Stanford Medical School, Stanford University, Stanford, CA Aziz A. Boxwala, M.B.B.S, Ph.D. Research Scientist and Instructor DSG, Harvard
More informationComparative effectiveness of dynamic treatment regimes
Comparative effectiveness of dynamic treatment regimes An application of the parametric g- formula Miguel Hernán Departments of Epidemiology and Biostatistics Harvard School of Public Health www.hsph.harvard.edu/causal
More informationTopic 3 Populations and Samples
BioEpi540W Populations and Samples Page 1 of 33 Topic 3 Populations and Samples Topics 1. A Feeling for Populations v Samples 2 2. Target Populations, Sampled Populations, Sampling Frames 5 3. On Making
More informationSurvival Analysis with Time- Dependent Covariates: A Practical Example. October 28, 2016 SAS Health Users Group Maria Eberg
Survival Analysis with Time- Dependent Covariates: A Practical Example October 28, 2016 SAS Health Users Group Maria Eberg Outline Why use time-dependent covariates? Things to consider in definition of
More informationSocial connectedness is associated with fibrinogen level in a human social network
SUPPLEMENTARY FIGURES AND TABLES FOR: Social connectedness is associated with fibrinogen level in a human social network David A. Kim, M.D., Ph.D. Emelia J. Benjamin, M.D., Sc.M. James H. Fowler, Ph.D.
More informationSchool of Science, Medicine & Health Michael J Macartney. Supervised By: Dr Gregory Peoples Prof Peter McLennan Mr Marc Brown
School of Science, Medicine & Health 2013 Michael J Macartney Supervised By: Dr Gregory Peoples Prof Peter McLennan Mr Marc Brown The Cardiac Branch The Vascular Branch Blood Pressure = CVD & all-cause
More informationRadiation Safety Protection for Callahan Eye Hospital (OHS_RS502)
Introduction Welcome to the Radiation Safety Protection for Callahan Eye Hospital Training Course (OHS_RS502). This training is designed and required for anyone working with or around Radioactive Materials
More informationMarginal Structural Cox Model for Survival Data with Treatment-Confounder Feedback
University of South Carolina Scholar Commons Theses and Dissertations 2017 Marginal Structural Cox Model for Survival Data with Treatment-Confounder Feedback Yanan Zhang University of South Carolina Follow
More information2015 ESMO Translational Research Fellowship Report
2015 ESMO Translational Research Fellowship Report Evaluation of c-met expression and inhibition in squamous cell carcinoma of the head and neck Petr Szturz University Hospital Brno, Czech Republic This
More informationPUBLIC HEALTH ASSOCIATION OF AUSTRALIA Strategic Plan
PUBLIC HEALTH ASSOCIATION OF AUSTRALIA Strategic Plan March 2017 20 Napier Close Deakin ACT Australia 2600 PO Box 319 Curtin ACT Australia 2605 Table of Contents Introduction... 2 Vision for a healthy
More informationSubstantiation of Disease and Health-Related Claims in Advertising. Washington, D.C.
Substantiation of Disease and Health-Related Claims in Advertising Food, Drug, and Law Institute Food Advertising, Labeling, and Litigation Conference September 13-14, 2017 Washington, D.C. Richard L.
More informationCairns Hospital: Suspected Acute Coronary Syndrome Pathways. DO NOT USE if a non cardiac cause for the chest pain can be diagnosed
Cairns Hospital: Suspected Acute Coronary Syndrome Pathways DO NOT USE if a non cardiac cause for the chest pain can be diagnosed Clinical pathways never replace clinical judgement. Care outlined on this
More informationEstimating Optimal Dynamic Treatment Regimes from Clustered Data
Estimating Optimal Dynamic Treatment Regimes from Clustered Data Bibhas Chakraborty Department of Biostatistics, Columbia University bc2425@columbia.edu Society for Clinical Trials Annual Meetings Boston,
More informationTable of Contents. The High 5s Project Interim Report
Annexes Table of Contents Annex 1 The High 5s Project and LTAs websites... 127 Annex 2 Culture survey: international comparative report... 129 Annex 3 Context survey report: Med Rec... 165 Annex 4A Event
More informationDeep Temporal Generative Models of. Rahul Krishnan, Uri Shalit, David Sontag
Deep Temporal Generative Models of Rahul Krishnan, Uri Shalit, David Sontag Patient timeline Jan 1 Feb 12 May 15 Blood pressure = 130 WBC count = 6*10 9 /L Temperature = 98 F A1c = 6.6% Precancerous cells
More informationTemsak Phungrassami, MD Division of Therapeutic Radiology, Faculty of. Prince of Songkla University
Palliative Care Goals & Assessment Temsak Phungrassami, MD Division of Therapeutic Radiology, Faculty of Medicine Prince of Songkla University Palliative Care Components 1. Pain and other symptoms relief
More informationUSING THE AC4FT-MINER PROCEDURE IN THE MEDICAL DOMAIN. Viktor Nekvapil
USING THE AC4FT-MINER PROCEDURE IN THE MEDICAL DOMAIN Viktor Nekvapil About the author 2 VŠE: IT 4IQ, 2. semestr Bachelor thesis: Using the Ac4ft-Miner procedure in the medical domain Supervisor: doc.
More informationModular Program Report
Modular Program Report The following report(s) provides findings from an FDA initiated query using its Mini Sentinel pilot. While Mini Sentinel queries may be undertaken to assess potential medical product
More informationNew Immigrant Survey Section D - Health
Section D: Health D1 {CP, IM, SP - Next I have some questions about your health. Would} {OS Would} you say your health is excellent, very good, good, fair, or poor? 1. EXCELLENT [D2; OS: E1a] 2. VERY GOOD
More informationCausal Inference with Big Data Sets
Causal Inference with Big Data Sets Marcelo Coca Perraillon University of Colorado AMC November 2016 1 / 1 Outlone Outline Big data Causal inference in economics and statistics Regression discontinuity
More informationThe Future of Healthcare? W H A T D O E S T H E F U T U R E H O L D? The Empowered Consumer
: : The Future of Healthcare? W H A T D O E S T H E F U T U R E H O L D? The Empowered Consumer Dr. Anne Anne W. Snowdon, W. Snowdon, RN, BScN, Chair MSc, PhD World Health Innovation Network, Odette School
More informationLectures of STA 231: Biostatistics
Lectures of STA 231: Biostatistics Second Semester Academic Year 2016/2017 Text Book Biostatistics: Basic Concepts and Methodology for the Health Sciences (10 th Edition, 2014) By Wayne W. Daniel Prepared
More informationState of Tennessee Department of Finance and Administration Bureau of TennCare
Bureau of TennCare : A COMPARATIVE ANALYSIS OF AUDITED RESULTS FROM TENNCARE MANAGED CARE ORGANIZATIONS (MCOS) September 2009 49 Music Square West, Suite 402 Nashville, TN 37203 Phone 866.514.8595 Fax
More informationINCREASING THE INTENSITY OF REHABILITATION FOR PATIENTS ON A SUB-ACUTE INPATIENT STROKE REHABILITATION UNIT:
INCREASING THE INTENSITY OF REHABILITATION FOR PATIENTS ON A SUB-ACUTE INPATIENT STROKE REHABILITATION UNIT: Seeking Efficiencies in Scheduling of Rehabilitation Esmé French frenche@tbh.net September 26,
More informationResearch Article. Thrombolytic potential of Punica granatum and lipid profile: A correlation analysis
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(3):534-540 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Thrombolytic potential of Punica granatum and lipid
More informationAnalysis of Longitudinal Data. Patrick J. Heagerty PhD Department of Biostatistics University of Washington
Analysis of Longitudinal Data Patrick J Heagerty PhD Department of Biostatistics University of Washington Auckland 8 Session One Outline Examples of longitudinal data Scientific motivation Opportunities
More informationInternal Audit Report
Internal Audit Report Right of Way Mapping TxDOT Internal Audit Division Objective To determine the efficiency and effectiveness of district mapping procedures. Opinion Based on the audit scope areas reviewed,
More informationReport of the Society of Actuaries Mortality Improvement. Survey Subcommittee
Report of the Society of Actuaries Mortality Improvement (Life Direct) Survey Subcommittee April 2012 Society of Actuaries 475 N. Martingale Rd., Ste. 600 Schaumburg, IL 60173 Phone: 847-706-3500 Fax:
More informationScalable Joint Modeling of Longitudinal and Point Process Data:
Scalable Joint Modeling of Longitudinal and Point Process Data: Disease Trajectory Prediction and Improving Management of Chronic Kidney Disease Joe Futoma (jdf38@duke.edu) UAI Bayesian Applications Workshop,
More informationExtending the results of clinical trials using data from a target population
Extending the results of clinical trials using data from a target population Issa Dahabreh Center for Evidence-Based Medicine, Brown School of Public Health Disclaimer Partly supported through PCORI Methods
More informationDivision of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series
Division of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series Year: 2013 #006 The Expected Value of Information in Prospective Drug Safety Monitoring Jessica M. Franklin a, Amanda R. Patrick
More informationT test for two Independent Samples. Raja, BSc.N, DCHN, RN Nursing Instructor Acknowledgement: Ms. Saima Hirani June 07, 2016
T test for two Independent Samples Raja, BSc.N, DCHN, RN Nursing Instructor Acknowledgement: Ms. Saima Hirani June 07, 2016 Q1. The mean serum creatinine level is measured in 36 patients after they received
More informationStatistical Issues in the Use of Composite Endpoints in Clinical Trials
Statistical Issues in the Use of Composite Endpoints in Clinical Trials Longyang Wu and Richard Cook Statistics and Actuarial Science, University of Waterloo May 14, 2010 Outline Introduction: A brief
More informationUniversal structures of normal and pathological heart rate variability (Supplemental Information)
Universal structures of normal and pathological heart rate variability (Supplemental Information) Alfonso M. Gañán-Calvo 1, Juan Fajardo-López 2 1 Depto. de Ingeniería Aeroespacial y Mecánica de Fluidos,
More informationRequirements for the Chemistry Major (B.A. and B.S.) The Major in Chemistry for the B.A. Degree consists of the following 39 hours:
CHEMISTRY (CHE) Degree offered: B.A. or B.S. Requirements for the Chemistry Major (B.A. and B.S.) The Major in Chemistry for the B.A. Degree consists of the following 39 hours: CHE 303 Quantitative Analysis
More informationSECTION D Monitoring plan as required in Annex VII of Directive 2001/18/EC
SECTION D Monitoring plan as required in Annex VII of Directive 2001/18/EC Type of monitoring plan The monitoring plan described in the submission is based on general surveillance. We believe this is a
More informationPurpose Study conducted to determine the needs of the health care workforce related to GIS use, incorporation and training.
GIS and Health Care: Educational Needs Assessment Cindy Gotz, MPH, CHES Janice Frates, Ph.D. Suzanne Wechsler, Ph.D. Departments of Health Care Administration & Geography California State University Long
More informationEvery day, health care managers must make decisions about service delivery
Y CHAPTER TWO FORECASTING Every day, health care managers must make decisions about service delivery without knowing what will happen in the future. Forecasts enable them to anticipate the future and plan
More informationIndividualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models
Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University July 31, 2018
More informationScience Course Descriptions
BIOLOGY I (L) 3024 (BIO I) Biology I is a course based on the following core topics: cellular chemistry, structure and reproduction; matter cycles and energy transfer; interdependence of organisms; molecular
More informationHEALTHCARE. 5 Components of Accurate Rolling Forecasts in Healthcare
HEALTHCARE 5 Components of Accurate Rolling Forecasts in Healthcare Introduction Rolling Forecasts Improve Accuracy and Optimize Decisions Accurate budgeting, planning, and forecasting are essential for
More informationCHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus
CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais Sanusi Datuk
More informationCausal Inference. Miguel A. Hernán, James M. Robins. May 19, 2017
Causal Inference Miguel A. Hernán, James M. Robins May 19, 2017 ii Causal Inference Part III Causal inference from complex longitudinal data Chapter 19 TIME-VARYING TREATMENTS So far this book has dealt
More informationCold Weather Plan. This Plan is to be read in conjunction with: Winter Plan Escalation and Surge Business Continuity Plans Major Incident Plan
Cold Weather Plan This Plan is to be read in conjunction with: Winter Plan Escalation and Surge Business Continuity Plans Major Incident Plan This Plan can be accessed from the Staff Zone Authorising Manager
More informationAccepted Manuscript. Comparing different ways of calculating sample size for two independent means: A worked example
Accepted Manuscript Comparing different ways of calculating sample size for two independent means: A worked example Lei Clifton, Jacqueline Birks, David A. Clifton PII: S2451-8654(18)30128-5 DOI: https://doi.org/10.1016/j.conctc.2018.100309
More informationEUROPEAN INVESTMENT BANK
EUROPEAN INVESTMENT BANK RISC Consortium and the UNU-CRIS Summer School/ Students Research Symposium, 3 rd July 2012, Luxembourg Regional Projects good practice? Kamil Dörfler 1 Outline General background
More informationAuditing and Investigations Overview
Painless Statistics for Compliance Professionals Blue Cross Blue Shield of Michigan Frank C. Castronova, PhD Health Management Bio Statistician (313) 448 1700 fcastronova@bcbsm.com Nova Compliance Group,
More informationAuditing and Investigations Overview
Painless Statistics for Compliance Professionals Blue Cross Blue Shield of Michigan Frank C. Castronova, PhD Health Management Bio Statistician (313) 448 1700 fcastronova@bcbsm.com Nova Compliance Group,
More informationInjury Related Morbidity and Mortality Following Tornadoes in Alabama on April 27, 2011: Survey Instrument Training
Injury Related Morbidity and Mortality Following Tornadoes in Alabama on April 27, 2011: Survey Instrument Training Live Webcast Monday, November 7, 2011 1:00 3:00 p.m. Central Time Produced by the Alabama
More informationhave been a number of high level and expert reviews including the most recent, the Marmot review.
QUESTIONS 5. Role of GPs and GP practices in public health: Are there additional ways in which we can ensure that GPs and GP practices will continue to play a key role in areas for which Public Health
More informationEXERTIONAL HEAT ILLNESS PREVENTION
EXERTIONAL HEAT ILLNESS PREVENTION MINIMIZING EXERTIONAL HEAT ILLNESS IN TRIATHLON The incidence of exertional heat stroke (EHS) varies from event to event and increases with rising ambient temperature
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Stability Indicating Analytical Method for Simultaneous Estimation of Perindopril and Potassium in Their Combined Marketed Dosage Form ABSTRACT: Gurjeet Kaur*, Nikhil Patel
More informationCHEMISTRY 100 : CHEMISTRY and MAN
CHEMISTRY 100 : CHEMISTRY and MAN Course Syllabus and Schedule Spring 2011 (CRN 33242) Instructor. Dr. Harry Davis. Office is in Kokio 116, the phone is 734-9186 and messages may be left on the answering
More informationCHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity
CHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity Prof. Kevin E. Thorpe Dept. of Public Health Sciences University of Toronto Objectives 1. Be able to distinguish among the various
More informationEast West Acupuncture & Wellness Center, Inc. Patient Intake Form
East West Acupuncture & Wellness Center, Inc. Patient Intake Form Date: / / How did you hear about us? ( )Ad ( ) Healthcare Referral ( ) Friend/Family Whom may we thank for the referral? Name DOB / / Age
More informationThank you for taking part in this survey! You will be asked about whether or not you follow certain forecasting practices.
23.08.13 13:21 INFORMED CONSENT Thank you for taking part in this survey! You will be asked about whether or not you certain forecasting practices. Your responses are anonymous. Results will be published
More informationMETHODS FOR STATISTICS
DYNAMIC CARTOGRAPHIC METHODS FOR VISUALIZATION OF HEALTH STATISTICS Radim Stampach M.Sc. Assoc. Prof. Milan Konecny Ph.D. Petr Kubicek Ph.D. Laboratory on Geoinformatics and Cartography, Department of
More informationAn extrapolation framework to specify requirements for drug development in children
An framework to specify requirements for drug development in children Martin Posch joint work with Gerald Hlavin Franz König Christoph Male Peter Bauer Medical University of Vienna Clinical Trials in Small
More informationRisk Assessment of Staphylococcus aureus and Clostridium perfringens in ready to eat Egg Products
Risk Assessment of Staphylococcus aureus and Clostridium perfringens in ready to eat Egg Products Introduction Egg products refer to products made by adding other types of food or food additives to eggs
More informationFaculty Disclosures Center for Health Research / Loma Linda University Pramil N. Singh, Dr.PH. No relevant commercial interests.
Faculty Disclosures Center for Health Research / Loma Linda University Pramil N. Singh, Dr.PH No relevant commercial interests. Geographic Information Systems for Health Care Research, Practice, and Management
More informationPremier Pain Consultants
Premier Pain Consultants Advanced Solutions For Pain Relief Name: DOB: Who is your primary care physician/family doctor? What is the major reason you are coming to see the doctor (chief complaint): How
More informationST 732, Midterm Solutions Spring 2019
ST 732, Midterm Solutions Spring 2019 Please sign the following pledge certifying that the work on this test is your own: I have neither given nor received aid on this test. Signature: Printed Name: There
More informationDesigning Information Devices and Systems I Fall 2016 Babak Ayazifar, Vladimir Stojanovic Homework 12
EECS 6A Designing Information Devices and Systems I Fall 206 Babak Ayazifar, Vladimir Stojanovic Homework 2 This homework is due November 22, 206, at P.M. Recommended Reading: Gilbert Strang, Introduction
More informationBiochemistry for Complementary Therapists
SUBJECT OUTLINE Subject Name: Biochemistry for Complementary Therapists SECTION 1 GENERAL INFORMATION Subject Code: BIOO211 Award/s: Total course credit points: Level: Bachelor of Health Science (Acupuncture)
More informationDoes the Lunar Cycle Affect Birth and Deaths?
Does the lunar cycle affect birth and deaths? 31 Journal of Articles in Support of the Null Hypothesis Vol. 11, No. 2 Copyright 2015 by Reysen Group. 1539-8714 www.jasnh.com Does the Lunar Cycle Affect
More informationEvaluating the Implementation of a Kidney Supportive Care program Queensland Experience
Evaluating the Implementation of a Kidney Supportive Care program Queensland Experience Prof Ann Bonner PhD, RN School of Nursing, Kidney Health Service, Metro North Hospital and Health Service NHMRC Chronic
More information